BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7930614)

  • 1. Topology of the loxoribine binding site. Studies with inactive loxoribine analogues.
    Goodman MG; Goodman JH
    J Immunol; 1994 Nov; 153(9):4081-7. PubMed ID: 7930614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
    Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
    Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunostimulatory compound 7-allyl-8-oxoguanosine (loxoribine) induces a distinct subset of murine cytokines.
    Pope BL; MacIntyre JP; Kimball E; Lee S; Zhou L; Taylor GR; Goodman MG
    Cell Immunol; 1995 May; 162(2):333-9. PubMed ID: 7743561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
    Pope BL; Chourmouzis E; Victorino L; MacIntyre JP; Capetola RJ; Lau CY
    J Immunol; 1993 Sep; 151(6):3007-17. PubMed ID: 8376766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective modulation of elements of the immune system by low molecular weight nucleosides.
    Goodman MG; Reitz AB; Chen R; Bobardt MD; Goodman JH; Pope BL
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1552-7. PubMed ID: 7562533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of lymphocytes by a thiol-derivatized nucleoside: characterization of cellular parameters and responsive subpopulations.
    Goodman MG; Weigle WO
    J Immunol; 1983 Feb; 130(2):551-7. PubMed ID: 6600242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo enhancement of murine natural killer cell activity by 7-allyl-8-oxoguanosine (loxoribine).
    Pope BL; Chourmouzis E; Sigindere J; Capetola RJ; Lau CY
    Int J Immunopharmacol; 1992 Nov; 14(8):1375-82. PubMed ID: 1464469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of immunostimulatory activity by dual substitution of C8-substituted guanine ribonucleosides: correlation with increased cytokine secretion.
    Pope BL; Chourmouzis E; Lee S; Goodman MG
    J Immunother Emphasis Tumor Immunol; 1995 Feb; 17(2):98-108. PubMed ID: 7647961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of 8-mercaptoguanosine-mediated adjuvanticity: roles of clonal expansion and cellular recruitment.
    Goodman MG; Weigle WO
    J Immunol; 1984 Dec; 133(6):2910-4. PubMed ID: 6208266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of salvage and phosphorylation in the immunostimulatory activity of C8-substituted guanine ribonucleosides.
    Goodman MG
    J Immunol; 1988 Oct; 141(7):2394-9. PubMed ID: 2459208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of inductive from differentiative signals transmitted by C8-substituted guanine ribonucleosides to B cells from SJL mice.
    Goodman MG; Weigle WO
    J Immunol; 1985 Jan; 134(1):91-4. PubMed ID: 3871118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule immunostimulants. Synthesis and activity of 7,8-disubstituted guanosines and structurally related compounds.
    Reitz AB; Goodman MG; Pope BL; Argentieri DC; Bell SC; Burr LE; Chourmouzis E; Come J; Goodman JH; Klaubert DH
    J Med Chem; 1994 Oct; 37(21):3561-78. PubMed ID: 7932584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation of spleen cells in culture stimulated by 7-thia-8-oxoguanosine: evidence that both B- and T-cells are the targets of its action.
    Colic M; Vucevic D; Vasilijic S; Popovic L; Pejanovic V; Jandric D; Medic-Mijacevic L; Rakic L
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):583-90. PubMed ID: 10669901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B lymphocytes from hyporesponsive SJL mice contain aberrant nucleoside binding sites.
    Goodman MG
    Cell Immunol; 1990 Sep; 129(2):377-84. PubMed ID: 2383897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity.
    Peng LS; Penichet ML; Morrison SL
    J Immunol; 1999 Jul; 163(1):250-8. PubMed ID: 10384123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of immunoglobulin secretion by a simple nucleoside derivative.
    Goodman MG; Weigle WO
    J Immunol; 1982 Jun; 128(6):2399-404. PubMed ID: 6281331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
    Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
    J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of acyl residues in polyclonal murine B cell activation by acylpoly(1,3)galactosides from Klebsiella pneumoniae.
    Hmama Z; Lina G; Normier G; Binz H; Revillard JP
    J Immunol; 1993 Nov; 151(10):5440-9. PubMed ID: 8228237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives on the approach to chronic lymphocytic leukemia.
    Goodman MG; Spinosa JC; Saven A; Piro LD; Wormsley S
    Leuk Lymphoma; 1996 Jun; 22(1-2):1-10. PubMed ID: 8724523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.